Improved Preservation of Residual Beta Cell Function by Atorvastatin in Patients with Recent Onset Type 1 Diabetes and High CRP Levels (DIATOR Trial)

BACKGROUND: A recent randomized placebo-controlled trial of the effect of atorvastatin treatment on the progression of newly diagnosed type 1 diabetes suggested a slower decline of residual beta cell function with statin treatment. Aim of this secondary analysis was to identify patient subgroups whi...

Descripción completa

Detalles Bibliográficos
Autores principales: Strom, Alexander, Kolb, Hubert, Martin, Stephan, Herder, Christian, Simon, Marie-Christine, Koenig, Wolfgang, Heise, Tim, Heinemann, Lutz, Roden, Michael, Schloot, Nanette C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3308960/
https://www.ncbi.nlm.nih.gov/pubmed/22448235
http://dx.doi.org/10.1371/journal.pone.0033108

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3308960/
https://www.ncbi.nlm.nih.gov/pubmed/22448235
http://dx.doi.org/10.1371/journal.pone.0033108

Ejemplares similares